Emotions in Multiple Sclerosis
Emotions Recognition in Multiple Sclerosis
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 20 months ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Carrying out a tests and questionnaires battery
What it measured
Main measures
Emotion's valence
Day 0
Thinking and memoryEmotion's intensity
Day 0
Thinking and memoryEmotion recognition
Day 0
Thinking and memoryCertainty's degree of answers
Day 0
Thinking and memory
Other measures (12)
California Verbal Learning Test (CVLT)
Day 0
Brief Visuo-spatial Memory Test (BVMT)
Day 0
Thinking and memorySymbol Digit Modalities Test (SDMT)
Day 0
Thinking and memoryStroop test
Day 0
Trail Making test
Day 0
Thinking and memoryVerbal fluency test
Dat 0
Beck Depression Inventory (BDI)
At the unique experimental session
Mood and sleepState Trait Anxiety Inventory Y-A (STAI Y-A)
Day 0
Mood and sleepState Trait Anxiety Inventory Y-B (STAI Y-B)
Day 0
Mood and sleepToronto Alexithymia Scale-20 (TAS-20)
Day 0
Who could take part
Relapsing MS · 18 to 55
Show the full criteria
Inclusion criteria
* Male or female between 18 and 55 years old. * Understand and able to express themselves in French. * EXPERIMENTAL GROUP : * Relapsing-remitting form (RRMS) * With an EDSS \< 4 (Expanded Disability Status Scale) * No significant motor, cerebellar or somatosensory disorders of the upper limbs or visual disorders (EDSS specific parameter \<2) * No flare-up in the last 6 weeks * No corticosteroids taken in the last 4 weeks * CONTROL GROUP : * Lack of global cognitive deterioration (according to Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) standards). * Gender, age and education level matching to the multiple sclerosis patients * Understanding and signing the informed consent and information letter regarding participation in the study. * Benefiting from health insurance coverage.
Exclusion criteria
* Persons with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general affections, perceptive or dysarthric disorders preventing verbal communication or reading, * People with sensory disorders (visual and auditory) that interfere with the performance of neuropsychological tests; * Treatment with psychotropic drugs (except benzodiazepines and hypnotics). * Refusal to participate after clear and fair information about the study. * Major persons under guardianship, under judicial protection, persons deprived of liberty. * Pregnant or breastfeeding women
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Through this study, a group composed of multiple sclerosis patients will be compared to a healthy volunteers group to determine if the positive emotions recognitions is preserved in the first group.
Papers
Loading reviews and guidelines…
History
Started
Jun 2021
Main results due
Feb 2025
Finished
Feb 2025